Indivior (INDV)

 

Latest News

SUBLOCADE(TM) Submitted in Australia for Approval

RNS Number: 3778P Indivior PLC 25 May 2018 Indivior Announces Regulatory Submission to Australia's Therapeutic Goods Administration (TGA)for SUBLOCADE (Buprenorphine Extended-Release) Injection for the Treatment of Opioid Dependence Slough, UK and Richmond, VA, 25 May 2018 - Indivior PLC (LON: INDV) today announced that it has filed a regu...

Indivior Participating in Jefferies NYC Conference

RNS Number: 0617P Indivior PLC 24 May 2018 Indivior's Mark Crossley to Participate in Jefferies 2018 Global Healthcare Conference on June 5 th Slough, UK , May 24, 2018- Indivior PLC (LON: INDV) today announced that Mark Crossley, CFO, will participate in Jefferies 2018 Global Healthcare Conference on Tuesday, June 5th, 2018, at 8:30 a.m. local time, in New Y...

Result of AGM

RNS Number: 3447O Indivior PLC 16 May 2018 IndiviorPLC (the 'Company') Poll results of4th Annual General Meeting ('AGM') May16,2018 The Company announces that at its AGM, held onMay16,2018, all resolutions set out in the Notice of AGM were passed on a poll. Resolutions1 to 18were passed as Ordinary Resolutions and Resolutions 19 to 22 were passed as Specia...

Broker Forecast - Citigroup issues a broker note on Indivior Plc

Citigroup today downgrades its investment rating on Indivior Plc (LON:INDV) to neutral (from buy) and raised its price t...

All News

DateHeadlineSource
25-05-18SUBLOCADE(TM) Submitted in Australia for ApprovalRNS
24-05-18Indivior Participating in Jefferies NYC ConferenceRNS
16-05-18Result of AGMRNS
15-05-18Broker Forecast - Citigroup issues a broker note on Indivior PlcStockMarketWire
14-05-18FTSE struggles to gain momentumStockMarketWire
14-05-18FTSE held back by weakness in miners and oil stocksStockMarketWire
14-05-18Indivior reaches settlement with Par PharmaceuticalStockMarketWire
14-05-18Indivior settlement with Par PharmaceuticalRNS
10-05-18Block listing Interim ReviewRNS
08-05-18Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
04-05-18Director/PDMR ShareholdingRNS
02-05-18Indivior profit falls as Suboxone cedes market shareStockMarketWire
02-05-181st Quarter ResultsRNS
20-04-18Uncertainty over May interest rate hike supports FTSEStockMarketWire
20-04-18FTSE rises amid shifting rate expectationsStockMarketWire
20-04-18Indivior files new drug submission in Canada for opoid abuse treatmentStockMarketWire
20-04-18Indivior's SUBLOCADE NDS Accepted by Health CanadaRNS
12-04-18Holding(s) in CompanyRNS
11-04-18Director DeclarationRNS
11-04-18Notice of ResultsRNS
09-04-18Broker Forecast - Jefferies International issues a broker note on Indivior PlcStockMarketWire
06-04-18Holding(s) in CompanyRNS
05-04-18FTSE bounces back as trade fears easeStockMarketWire
05-04-18Indivior files patent infringement lawsuits for SuboxoneStockMarketWire
05-04-18Indivior Asserts New SUBOXONE(R) Film PatentRNS
04-04-18Director/PDMR ShareholdingRNS
03-04-18Holding(s) in CompanyRNS
03-04-18Broker Forecast - Morgan Stanley issues a broker note on Indivior PlcStockMarketWire
03-04-18Total Voting RightsRNS
29-03-18Indivior and C4X Enter Licensing AgreementRNS
27-03-18Holding(s) in CompanyRNS
23-03-18FTSE struggles to gain ground against stronger poundStockMarketWire
23-03-18Broker Forecast - Numis issues a broker note on Indivior PlcStockMarketWire
23-03-18FTSE resilient as trade war fears hit global marketsStockMarketWire
23-03-18Indivior warns 'material loss' of market share for Suboxone amid US court rulingStockMarketWire
23-03-18Indivior Responds to Court Ruling ANDA litigationRNS
22-03-18Annual Financial ReportRNS
13-03-18Director Deals - Indivior Plc (INDV)StockMarketWire
13-03-18Director Deals - Indivior Plc (INDV)StockMarketWire
13-03-18Director/PDMR ShareholdingRNS

RSS feeds

  • Editorial news feed for LSE:INDV Editorial
  • Regulatory news feed for LSE:INDV Regulatory